Please wait while the search results are loading...

Fast Track Drugs Come to Market in the U.S. with FDA Cooperation, Business and Industry Trends Analysis

Despite exponential advances in biopharmaceutical knowledge and technology, biotech companies enduring the task of getting new drugs to market continue to face long timeframes, daunting costs and immense risks.  By one count, of every 1,000 experimental drug compounds in some form of pre-clinical testing, only one makes it to clinical trials.  Then, only one in five of those drugs make it to market.  Of the drugs that get to market, only one in three bring in enough revenue to recover their costs.  Meanwhile, the patent expiration clock is ticking—soon enough, manufacturers of generic alternatives steal market share from the firms that invested all that time and money in the development of the original drug.

Internet Research Tip:
The FDA regulates biologic products for use in humans.  It is a source of a broad variety of data on drugs, including vaccines, blood products, counterfeit drugs, exports, drug shortages, recalls and drug safety.


A Representative List of Organizations that Have Used our Research and Products:



Testimonials

I’m amazed at how much information is available and the various ways to access it. This will be a major resource for our serious job seekers.

Career Services, Penn State University

Plunkett Research Online provides a great ‘one stop shop’ for us to quickly come up to speed on major industries. It provides us with an overall analysis of the market, key statistics, and overviews of the major players in the industry in an online service that is fast, easy to navigate, and reliable.

Wendy Stotts, Manager, Carlson Companies

I really appreciate the depth you were able to get to so quickly (for our project). The team has looked through the material and are very happy with the data you pulled together.

Hilton Worldwide, Marketing Manager
Real Time Web Analytics preload imagepreload image